Understanding how T cell receptors detect cellular changes
Protein Production
This study is looking at how a part of your immune system called the T cell receptor works, which could help us understand and improve treatments for autoimmune diseases and cancer.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10877942 on NIH RePORTER |
What this research studies
This research focuses on the T cell receptor (TCR), which plays a crucial role in the immune response by detecting changes in cells due to infections or cancer. The project aims to explore the molecular mechanisms of TCR function using advanced techniques like single molecule analysis and X-ray crystallography. By producing various forms of TCR proteins, the research will enhance our understanding of how these receptors operate and interact with other cellular components. This could lead to new insights into autoimmune diseases and cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with autoimmune diseases or those at risk for malignancies.
Not a fit: Patients with non-autoimmune conditions or those not affected by T cell-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for autoimmune diseases and cancer by enhancing our understanding of T cell function.
How similar studies have performed: Previous research has shown promising results in understanding T cell biology, indicating that this approach could yield significant advancements.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Mallis, Robert Joseph — Dana-Farber Cancer Inst
- Study coordinator: Mallis, Robert Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.